Library search
Canadian Risky Business: Why Fair and Predictable Patentable Utility is Critical to Investments and Innovation
Investment in innovation and procurement of patent protection within any jurisdiction is justified by reliance upon fair and predictable patent protection. For new investment within any particular jurisdiction, innovators expect...Read more
Arvie Anderson
Assistant General Patent Counsel, Eli Lilly and Company, USA
R&D Based Pharmaceutical Companies Vs. Generic Companies: A False Dichotomy?
As recently as a decade ago, there was a clear line separating R&D-based pharmaceutical companies and generic companies; on one side were innovator pharmaceutical companies focused on developing innovative new...Read more
Sharon Reiche
Corporate Counsel, Intellectual Property Policy, Pfizer Inc, USA
Data Protection in the Pharmaceutical Industry: Concerns and Considerations
Data protection is an important aspect of the pharmaceutical industry throughout all stages of a product lifecycle – from innovation to exit. In the early stages of product development, manufacturers...Read more
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
Pharmaceutical Patent Protection in Turkey
Between 1994 and 1995, Turkey conducted necessary legislative studies to establish an efficient and contemporary industrial property system and obtained very important concrete results. Turkey has ratified many international agreements...Read more
Gaye Ramazanoglu Partlak
Intellectual Property Specialist, Sanovel Ilac San.ve Tic. A.S., Turkey
Pharmaceutical Ethic Codes: How to draft a Pharmaceutical Ethic Codes without inhibiting your business
Pharmaceutical Industry is very risky business, not only that the company needs to grow its profit but it must show to the people that they contribute to the human health...Read more
Tri Junanto Wicaksono
Head of GA & Legal, PT. Amerta Indah Otsuka, Indonesia
Doing Business in Brazil
The entry of Brazil into the Emerging Markets Group, leading the Latin America economy, increased the number of players interested in the Brazilian pharmaceutical market. Brazilian Legislation has been in...Read more
Fátima Picôto
Legal Director Brazil, Glaxosmithkline Brasila, Brazil
Increased Evolution of Regulations Affecting the Pharmaceutical Law Practice
The increase of regulations over the last two to five years for pharmaceutical companies has become a nightmare for sales representatives working for those companies and for internal staff charged...Read more
Jean Frydman
Partner, Fox Rothschild , USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective
The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
US and International Codes on Pharmaceutical Marketing Practices and Interaction with Healthcare Professionals - A Comparative Analysis and Outlook on Harmonization by FCPA Enforcement
In recent years, there has been an increasing focus on pharmaceutical marketing practices and interactions between pharmaceutical companies and healthcare professionals. Concerns about real and perceived improprieties have led to...Read more
Roy Birnbaum
Counsel, Human Health International, Merck & Co, Inc., USA
Pharmaceutical Advertising in Denmark - Where did Freedom of Expression go?
Differences in the legal approach to advertisement of pharmaceuticals still exist within the European Union even though Directive 2001/83/EC of the European Parliament and of the Council of 6 November...Read more
Nicolai Ellehuus
Attorney-at-Law, Novo Nordisk Inc, USA